Shopify, Sirius XM, Evoke Pharma Stocks Moving Today

Shopify, Sirius XM, and Evoke Pharma stocks are some of the top gainers today on Wall Street

Feb 15, 2017 at 1:32 PM
facebook X logo linkedin

U.S. stocks are once again hitting record highs today. Among specific equities in focus are e-commerce specialist Shopify Inc (NYSE:SHOP), satellite radio provider Sirius XM Holdings Inc. (NASDAQ:SIRI), and drug stock Evoke Pharma Inc (NASDAQ:EVOK). Here's a quick look at what's moving shares of SHOP, SIRI, and EVOK.

Wall Street Cheers Shopify Forecast

SHOP is barreling to new highs, following the company's impressive fourth-quarter earnings report, and upwardly revised full-year forecast. At last check, the shares were up 5.3% at $59.01, after touching a record peak of $60.05 earlier. Shopify Inc has nearly tripled in value over the past 12 months, with rumors of an Amazon partnership sparking a sharp upside move last month. In the meantime, put buying has nearly tripled call buying during the past two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Elsewhere, Canaccord Genuity just lifted its price target to $68 from $52.

Berkshire Stake Sends Sirius XM to New Highs

SIRI is one of a number of stocks on the move due to recent SEC filings, with the stock adding 2.8% to trade at $4.88, on news Warren Buffett's Berkshire Hathaway Inc. (NYSE:BRK.A) purchased nearly 167 million shares. For the most part, Sirius XM Holdings Inc. has been grinding higher since early 2009, and touched a more than 10-year high of $4.90 earlier. Interestingly, it seems a number of options traders were betting on an upside move, as nearly 10,600 calls were bought to open across the ISE, CBOE, and PHLX during the past two weeks, compared to just 249 puts. 

FDA Nod Sparks Evoke Pharma Rally

EVOK is surging, after the Food and Drug Administration (FDA) exempted the company's nasal spray, Gimoti, from a human factors validation study. The company now plans to submit a marketing application by the end of the year. As for the stock, it was last seen up 40% at $3.65, on pace for its first close atop the 200-day moving average since July. Of course, this is terrible news for Evoke Pharma Inc short sellers, who control 16.5% of the stock's float. 

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI